These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 2577697)
1. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. Murphy WA; Taylor JE; Moreau JP; Coy DH Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697 [TBL] [Abstract][Full Text] [Related]
2. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells. Presky DH; Schonbrunn A Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related]
5. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase. Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of receptors for somatostatin in various tumors using different analogs. Srkalovic G; Cai RZ; Schally AV J Clin Endocrinol Metab; 1990 Mar; 70(3):661-9. PubMed ID: 1968467 [TBL] [Abstract][Full Text] [Related]
9. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. Raynor K; Reisine T J Pharmacol Exp Ther; 1989 Nov; 251(2):510-7. PubMed ID: 2572690 [TBL] [Abstract][Full Text] [Related]
10. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies. Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843 [TBL] [Abstract][Full Text] [Related]
11. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212 [TBL] [Abstract][Full Text] [Related]
12. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8. Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20. Mahy N; Woolkalis M; Manning D; Reisine T J Pharmacol Exp Ther; 1988 Oct; 247(1):390-6. PubMed ID: 2902214 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells. Schonbrunn A; Rorstad OP; Westendorf JM; Martin JB Endocrinology; 1983 Nov; 113(5):1559-67. PubMed ID: 6138246 [TBL] [Abstract][Full Text] [Related]
15. Peptides and antitumor activity. Development and investigation of some peptides with antitumor activity. Teplán I Acta Biol Hung; 2000; 51(1):1-29. PubMed ID: 10866357 [TBL] [Abstract][Full Text] [Related]